wholly

Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model

Company Announcement Genmab to acquire Merus for USD 97.00 per share in an all-cash transaction representing a transaction value of…

2 months ago

Fermenta Board Approves Sale of Environmental Solutions Business to Wholly Owned Subsidiary

Strategic transfer to enhance operational focus and create dedicated environmental solutions platformTo enable specialized management and accelerated growth of environmental…

3 months ago

Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilexs Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to a f

June 23, 2025 16:50 ET  | Source: Scilex Holding Company PALO ALTO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Scilex…

5 months ago